Recent advance in the understanding of iron metabolism and its role on host defense

Japanese Journal of Clinical Immunology

Volumn 28, Issue 6, 2005, Pages 372-380

  Hishikawa, Kyoko ^a   Iwai, Kazuhiro ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

hepcidin; IRE; iron; iron refractory anemia; IRP

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; HEPCIDIN; IRON; IRON REGULATORY FACTOR;

BACTERIAL INFECTION; HUMAN; IMMUNOLOGY; IRON DEFICIENCY ANEMIA; METABOLISM; PHYSIOLOGY; REVIEW;

ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; HUMANS; IRON; IRON-REGULATORY PROTEINS;

EID: 33644836576     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.28.372     Document Type: Article

References (29)

1. Nemeth, E., Valore, E. V., Territo, M. et al.: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461–2463, 2003.
2. Klausner, R. D., Rouault, T. A. and Harford, J. B.: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72: 19–28, 1993.
3. Heathcote, E. J.: Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 127: S294-S302, 2004.
4. Andrews, N. C.: Iron homeostasis: insights from genetics and animal models. Nat Rev Genet 1: 208–217, 2000.
5. Hentze, M. W., Muckenthaler, M. U. and Andrews, N. C.: Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285–297, 2004.
6. Gunshin, H., Mackenzie, B., Berger, U. V. et al.: Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482–488, 1997.
7. Shayeghi, M., Latunde-Dada, G. O., Oakhill, J. S. et al.: Identification of an intestinal heme transporter. Cell 122: 789–801, 2005.
8. Anderson, G. J., Frazer, D. M., McKie, A. T. et al.: The expression and regulation of the iron transport molecules hephaestin and IREG1: implications for the control of iron export from the small intestine. Cell Biochem Biophys 36: 137–146, 2002.
9. Yoshida, K., Furihata, K., Takeda, S. et al.: A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9: 267–272, 1995.
10. Harris, Z. L., Takahashi, Y., Miyajima, H. et al.: Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 92: 2539–2543, 1995.
11. Park, C. H., Valore, E. V., Waring, A. J. et al.: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806–7810, 2001.
12. Pigeon, C., Ilyin, G., Courselaud, B. et al.: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811–7819, 2001.
13. Ganz, T.: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783–788, 2003.
14. Nemeth, E., Tuttle, M. S., Powelson, J. et al.: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090–2093, 2004.
15. Nicolas, G., Bennoun, M., Devaux, I. et al.: Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98: 8780–8785, 2001.
16. Nicolas, G., Bennoun, M., Porteu, A. et al.: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99: 4596–4601, 2002.
17. Flo, T. H., Smith, K. D., Sato, S. et al.: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917–921, 2004.
18. Feder, J. N., Gnirke, A., Thomas, W. et al.: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399–408, 1996.
19. Rothenberg, B. E. and Voland, J. R.: beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 93: 1529–1534, 1996.
20. Iwai, K.: An ubiquitin ligase recognizing a protein oxidized by iron: implications for the turnover of oxidatively damaged proteins. J Biochem (Tokyo) 134: 175–182, 2003.
21. Meyron-Holtz, E. G., Ghosh, M. C., Iwai, K. et al.: Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. Embo J 23: 386–395, 2004.
22. Iwai, K., Klausner, R. D. and Rouault, T. A.: Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. Embo J 14: 5350–5357, 1995.
23. Iwai, K., Drake, S. K., Wehr, N. B. et al.: Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci USA 95: 4924–4928, 1998.
24. Yamanaka, K., Ishikawa, H., Megumi, Y. et al.: Identification of the ubiquitin protein ligase that recognizes oxidized IRP2. Nat Cell Biol 5: 336–340, 2003.
25. Ishikawa, H., Kato, M., Hori, H. et al.: Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol Cell 19: 171–181, 2005.
26. Finch, C.: Regulators of iron balance in humans. Blood 84: 1697–1702, 1994.
27. Beutler, E.: Hemochromatosis: Genetics and Pathophysiology. Annu Rev Med 2006.
28. Andrews, N. C.: Anemia of inflammation: the cytokinehepcidin link. J Clin Invest 113: 1251–1253, 2004.
29. Hayashi, H., Takikawa, T., Nishimura, N. et al.: Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 89: 986–988, 1994.